| Literature DB >> 30307150 |
Sujith Rajan1,2, Ganesh Panzade3,4, Ankita Srivastava1,2, Kripa Shankar1, Rajesh Pandey5, Durgesh Kumar1,2, Sanchita Gupta1,2, Abhishek Gupta1, Salil Varshney1,2, Muheeb Beg1, Raj Kumar Mishra6, Ravi Shankar3,4, Anil Gaikwad1,2.
Abstract
miRNA has been known to regulate diverse cellular and molecular functions. In the earlier study, we have reported that adipocytes differentiated from human mesenchymal stem cells (hMSC) on 72-h chronic insulin (CI) treatment exhibit insulin resistance (IR). Present study has further explored above model to investigate the role of early expressed miRNAs within human adipocytes to modulate differential adipokine expression as observed during IR. Our results highlight that miR-876-3p regulate glucose homeostasis and its dysregulation leads to IR. We found that miR-876-3p level is a critical determinant of adiponectin expression by virtue of its target within adiponectin 3′UTR. Regulatory effect of miR-876-3p impacts crosstalk between adiponectin and insulin signaling. Rosiglitazone treatment in CI-induced IR adipocytes drastically reduced miR-876-3p expression and increased adiponectin level. In line with this, lentiviral-mediated inhibition of miR-876-3p expression ameliorated CI and high-fat diet (HFD)-induced IR in adipocytes differentiated from hMSC and C57BL/6 mice, respectively. Our findings thus suggest that modulating miR-876-3p expression could provide novel opportunities for therapeutic intervention of obesity-associated metabolic syndrome. 2018 Society for EndocrinologyEntities:
Keywords: insulin resistance; miRNA; adiponectin; next generation sequencing; adipokines
Mesh:
Substances:
Year: 2018 PMID: 30307150 DOI: 10.1530/JOE-17-0387
Source DB: PubMed Journal: J Endocrinol ISSN: 0022-0795 Impact factor: 4.286